Product Information
CRYSELLE-28 TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.2930 per EA under NDC 00480349316. Its NADAC has been published 30 times since Jan 28, 2026.
FDA first approved this application on Nov 30, 2001. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00480349316
Classification
Generic
Dosage Form
KIT
Route
ORAL
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA075840FDA Approved
11/30/2001
TE Code
AB
On Market Since
12/12/2025
Price Statistics
The NADAC for CRYSELLE-28 TABLET has been published 30 times since Jan 28, 2026, and over the history we have for it it has declined 17.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2930 per EA |
|---|---|
| All-time high | $0.3538 (Feb 11, 2026) |
| All-time low | $0.2841 (Jul 22, 2026) |
| 52-week high | $0.3538 |
| 52-week low | $0.2841 |
| Median price | $0.2990 |
| Average price | $0.3050 |
| Largest weekly change | -8.7% (Feb 18, 2026) |
| Weeks tracked | 30 |
| Tracking since | Jan 28, 2026 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CRYSELLE-28 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CRYSELLE-28 TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.2930 per EA (NDC 00480349316), effective Aug 19, 2026.
How has the price of CRYSELLE-28 TABLET changed over time?
Over the history we have for it, the NADAC for CRYSELLE-28 TABLET has declined 17.2%. It has been tracked across 30 weekly CMS publications since Jan 28, 2026.
What are the highest and lowest recorded NADAC prices for CRYSELLE-28 TABLET?
Since Jan 28, 2026, the NADAC for CRYSELLE-28 TABLET has ranged from a low of $0.2841 (Jul 22, 2026) to a high of $0.3538 (Feb 11, 2026), with a median of $0.2990 per EA.
Are there cheaper alternatives to CRYSELLE-28 TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CRYSELLE-28 TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CRYSELLE-28 TABLET?
CRYSELLE-28 TABLET (NDC 00480349316) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.